NEW YORK (GenomeWeb News) – Source BioScience said this week that it has extended its next-generation sequencing services to include the Illumina MiSeq platform. The UK-based genomics services and molecular diagnostics firm said that it is the only commercial provider of the platform in the UK and added that the MiSeq will enable it to apply next-generation sequencing to molecular diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.